Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
EZI @ EICMA 2025: Redefining Electric Light Mobility with Ai-Native EM05
-
Next Hydrogen Announces $20 to $30M Equity Private Placement led by Smoothwater Capital Corporation
-
REPEAT – Dorel Industries Will Hold a Conference Call to Discuss Its Third Quarter Results
-
Marimaca Regretfully Announces the Passing of Colin Kinley
-
New Pooled 3-Year Analysis Confirms Sustained, Clinically Meaningful Improvements in Renal Function for TransCon® PTH (Palopegteriparatide)-Treated Adults with Hypoparathyroidism
-
Star Equity Holdings to Release Third Quarter 2025 Financial Results on November 13
-
Bath & Body Works Declares Cash Dividend
-
Greenstone Provides Update on Holdings of Highland Copper Company Inc.
-
Bosuer Electrifies EICMA 2025 with Strategic Debut of Its High-Performance Off-Road Matrix
-
Biotricity to Host Fiscal 2026 Second Quarter Financial Results and Business Update Call on November 14th
-
ODYSIGHT.AI ANNOUNCES COMMERCIAL PURCHASE ORDER FOR 200 INDUSTRIAL PREDICTIVE MONITORING SYSTEMS FOR ELEVATORS
-
NRSInsights’ October 2025 Retail Same-Store Sales Report
-
Champion Safe Celebrates Hyatt Coin Shop for 30% Year-Over-Year Growth in the Southeast
-
Navitas Announces Private Placement of Common Stock for Proceeds of $100 Million
-
HUHUTECH’s U.S. Subsidiary Secures First Order Worth $3.0 Million, Marking a Breakthrough Following Its Nasdaq IPO
-
Lianhe Sowell International Group Ltd Announces Approval of Dual-Class Share Structure by Shareholders
-
WKSP Invites You to Join Its Third Quarter 2025 Earnings Conference Call
-
Wave Life Sciences to Present at Upcoming Investor Conferences
-
IPDN Welcomes His Highness Shaikh Ali Sultan Al Nuaimi of the UAE Royal Family as Independent Director
-
Form 8.3 - Qualcomm Incorporated
-
IES Holdings to Acquire Gulf Island Fabrication
-
ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Legacy Housing Announces Agreement to Purchase Assets of AmeriCasa Solutions, LLC and Addition of New Senior Management
-
Altimmune Presents AI-Based Analysis of Liver Fibrosis Reduction from IMPACT Phase 2b Trial of Pemvidutide in MASH in Late-breaking Poster at AASLD The Liver Meeting® 2025
-
IMUNON R&D Day: Opportunity to Hear Clinical Trial Investigators Discuss Significant Potential of IMNN-001 to Redefine Ovarian Cancer Treatment
-
IMUNON R&D Day: Opportunity to Hear Clinical Trial Investigators Discuss Significant Potential of IMNN-001 to Redefine Ovarian Cancer Treatment
-
Treace Announces Participation in Two Upcoming Investor Conferences
-
PlainsCapital Bank Recognized for Strong Support of North Texas Food Bank through Truck Sponsorship
-
Celldex to Present at Upcoming Investor Conferences
-
Conduent Reports Third Quarter 2025 Financial Results
-
Karbon-X Expands Blue Carbon Leadership with New Restoration Project in Guinea
-
MAX Power Begins Historic Drilling of Canada’s First-Ever Natural Hydrogen Well
-
ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2025
-
Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing
-
Atea Pharmaceuticals Presents New Data Supporting the Fixed-Dose Combination of Bemnifosbuvir and Ruzasvir as a Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus Infection at The Live
-
Black Friday Starts Early at Curacao: Three Weeks of Massive Savings You Can’t Miss
-
Vor Bio to Participate in Upcoming Investor Conferences
-
Vaxart to Host Upcoming Conference Calls
-
Dupixent® (dupilumab) Pivotal Trial Met All Primary and Secondary Endpoints, Reducing Signs and Symptoms of Allergic Fungal Rhinosinusitis (AFRS); sBLA Accepted for FDA Priority Review
-
Biofrontera Inc. announces sale of license to Xepi® Antibiotic Cream to Pelthos Therapeutics Inc. for up to $10M
-
AirJoule Technologies Schedules Release of Third Quarter 2025 Results and Conference Call
-
Rivus Pharmaceuticals Announces New Data from Phase 2 M-ACCEL Trial of HU6 in MASH in Late-Breaker Oral Presentation at AASLD The Liver Meeting® 2025
-
Dycom Industries, Inc. to Host Fiscal 2026 Third Quarter Results Conference Call
-
Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025
-
Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®
-
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
-
ESET to aid MSPs by integrating with ConnectWise Asio
-
Dr. Adrian Bot joins Immuthera to support the company with his unique experience in commercialization of groundbreaking cell therapies
-
Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA pri
-
Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting
